
|Articles|August 13, 2015
GSK: Legionnaires Disease Bacteria Causes Temporary Closedown of US Site
August 13, 2015.
Advertisement
The
GSK said the bacteria had been isolated after routine testing and that it is “working to rectify and restore operations as soon as possible”.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
4
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
5




